piritrexim has been researched along with Glioma in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bedford, P; Bleehen, NM; Nethersell, AB; Newman, HV; Rampling, RP; Ramsay, JR; Roberts, JT | 1 |
| Adamson, PC; Arndt, C; Aronson, L; Balis, FM; Clendeninn, NJ; Gillespie, A; Miser, J; Penta, JS; Poplack, DG; Wells, RJ | 1 |
2 trial(s) available for piritrexim and Glioma
| Article | Year |
|---|---|
A phase II study of oral piritrexim in recurrent high-grade (III, IV) glioma.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Brain Neoplasms; Drug Administration Schedule; Female; Folic Acid Antagonists; Glioma; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pyrimidines | 1995 |
Pediatric phase I trial, pharmacokinetic study, and limited sampling strategy for piritrexim administered on a low-dose, intermittent schedule.
Topics: Adolescent; Adult; Antineoplastic Agents; Brain Neoplasms; Child; Child, Preschool; Drug Administration Schedule; Drug Evaluation; Female; Glioma; Humans; Leukocyte Count; Male; Neoplasms; Platelet Count; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Sarcoma | 1992 |